Feng Zhang’s base-editing CRISPR startup officially launches with $87M – FierceBiotech
FierceBiotech |
Feng Zhang's base-editing CRISPR startup officially launches with $87M
FierceBiotech Feng Zhang's latest CRISPR company, Beam Therapeutics officially came out of stealth Monday, with $87 million in series A funding and a mission to develop "precision genetic medicines" that use CRISPR technology to edit just one nucleotide base, … CRISPR trailblazers Zhang, Liu and Joung join forces to launch Beam with $87M and cutting-edge gene-editing tech Harvard and MIT launch gene editing company A startup that wants to make treatments that edit single letters in our DNA just raised $87 million |
